Liquid biopsy tools detect diseases at low cost

-
Featured Image

Revolutionary Devices for Rapid Disease Diagnosis

In recent years, there has been significant progress in the development of devices that can rapidly diagnose a wide range of diseases. These include emerging infectious diseases such as COVID-19, Lyme disease, and AIDS, as well as chronic conditions like cancer and dementia. The key to this advancement lies in the rapid development of "liquid biopsy" technology, which allows for the detection of disease markers through substances found in the blood.

A notable breakthrough came from a research team at Arizona State University (ASU) in the United States. They developed an innovative device called "NasRED," which is capable of diagnosing various emerging infectious diseases from just a single drop of blood. This groundbreaking discovery was published in the prestigious international academic journal ACS Nano on the 12th of last month.

According to the ASU research team, the NasRED device is a compact cube measuring 6.7 cm on each side. It is not only portable but also highly accurate and sensitive. The device can detect even the smallest amounts of biological markers in the blood. For instance, it can identify disease indicators in a volume of blood equivalent to a single drop of ink in a large body of water—such as 20 Olympic-sized swimming pools. The cost of using this device is remarkably low, at just $2 per diagnosis. The researchers emphasized that the use of this device could enable a swift response to infectious diseases before they spread widely.

Advancements in Dementia Detection

Another significant development comes from Fuji Revio Diagnostics, a subsidiary of the Fuji Revio Group in Japan. In May, the company received approval from the U.S. Food and Drug Administration (FDA) for its blood test kit called "Lumipulse." This kit is designed to differentiate and diagnose diseases, even when only a small amount of dementia-related proteins are present in the blood. This innovation offers a promising approach for early detection of neurodegenerative conditions.

Early Cancer Detection Technology

Grail, a leading U.S.-based company specializing in liquid biopsy technology, has made headlines with its "Multi-Cancer Early Detection (MCED) test." This advanced technology can detect the presence of cancer cells in over 20 different types of cancer, often up to three years before symptoms appear. The company is currently seeking FDA approval for this groundbreaking test, which could revolutionize the way cancer is diagnosed and treated.

Innovations in South Korea

South Korea has also contributed to the field of liquid biopsy with the launch of "ai-CANCERCH" by GC Genome in 2023. This test, available domestically, can predict the likelihood of six types of cancer based on a single blood draw. It is particularly effective in identifying the risk of lung cancer, liver cancer, colorectal cancer, pancreatic cancer, esophageal cancer, and ovarian cancer. The ability to detect these cancers early can significantly improve patient outcomes and treatment options.

The Future of Diagnostic Technology

The advancements in liquid biopsy technology are reshaping the landscape of medical diagnostics. With devices like NasRED, Lumipulse, and ai-CANCERCH, the future looks promising for early and accurate detection of a wide range of diseases. These innovations not only enhance diagnostic capabilities but also make healthcare more accessible and affordable. As research continues, we can expect even more sophisticated tools that will further improve patient care and public health outcomes.

Comments

Post a Comment

Popular posts from this blog

Japan Firms Leverage Satellites and AI to Locate Abandoned Homes for Sale

-
Image
The Rise of AI-Powered Real Estate Discovery in Japan In Tokyo, a growing number of Japanese companies are leveraging satellite imagery and artificial intelligence to identify abandoned houses that could be repurposed or sold. This innovative approach is becoming increasingly vital as the country faces a rising number of deserted properties due to its aging population. Where Inc., a startup, offers a service that uses AI trained on tens of thousands of images to detect signs of aging roofs, such as rust and discoloration. These findings are then overlaid on satellite maps, helping users spot properties that may have been left unattended. One of Where Inc.'s users, Kotaro Yasue, recently discovered a two-story wooden house through this service. He was able to contact the owner via a real estate registry. It turned out that the house had been neglected for over a decade, and the owner was unsure how to proceed with its disposal. Yasue, who runs a house rental service company in G...
Read more

GEN Nigeria and Others Target Indigenous Firms with New Tech Fees

-
Image
Empowering Nigerian Entrepreneurs with AI Global Entrepreneurship Network (GEN Nigeria), in collaboration with Fidelity Bank Plc and other organizations, has called on young entrepreneurs in Nigeria to embrace new technologies, particularly Artificial Intelligence (AI), in their business operations. This initiative was highlighted during the Youth Entrepreneurship Dialogue, titled “Building the Future with AI: Technology, Talent, and Transformation Entrepreneurship,” which took place at the 2025 Global Entrepreneurship Week (GEW) in Lagos. Dr. Olawale Anifowose, the Managing Director of GEN Nigeria, emphasized that AI has become essential for local enterprises in Nigeria to boost productivity, drive innovation, and enhance competitiveness. According to Anifowose, this can be achieved by automating tasks, personalizing customer experiences through data analysis, and enabling entrepreneurs to develop and scale new products and services more efficiently. Enhancing Efficiency and Produc...
Read more

I Was Healthy Until a Dirty Habit Stopped My Heart

-
Image
A Rare Case of Cannabis-Induced Cardiac Arrest in a Young, Healthy Woman A 26-year-old woman from Georgia experienced a life-threatening cardiac arrest after smoking marijuana. The incident occurred when her fiancé discovered her unconscious on the bathroom floor, prompting immediate emergency medical intervention. Upon arrival at the hospital, doctors confirmed that she had suffered a cardiac arrest, where the heart suddenly stopped beating. The woman had no known pre-existing health conditions and tested negative for heart-related issues such as arrhythmia. However, she was found to have high levels of tetrahydrocannabinol (THC), the psychoactive compound in cannabis responsible for the "high" sensation. Doctors diagnosed her with ventricular fibrillation, a severe heart rhythm disorder that prevents the heart from effectively pumping blood and oxygen throughout the body. This led to what they described as a "cannabis-induced cardiac arrest." This case has rais...
Read more